Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Enbrel improves plaque psoriasis symptoms in phase III study

June 27, 2003

VIC-acne completes phase I safety study

June 25, 2003

Shiseido synthesizes new MMP inhibitors

June 23, 2003

Dompe patents novel inhibitors of IL-8 and GROalpha-induced chemotaxis

June 18, 2003

Interim results for rAAT in otitis media

June 17, 2003

Fibrostat phase IIb trial cleared to commence

June 16, 2003

Nonhypercalcemic vitamin D analogues newly synthesized at Schering AG

June 16, 2003

Reepithelialization of second degree burns enhanced in pigs administered CNI-1493

June 16, 2003

Novel glucocorticoid agonists in early development at GSK

June 13, 2003

Life Medical Sciences cleared to begin pivotal trial of Repel-CV

June 12, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 13, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...